| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
August 28, 2023 |
|
|
| |
|
|
| |
|
|
|
Xtalks, online
2023 -9-26
The science has been established and proven, and your product has received FDA approval. Now with product launch training becoming a critical aspect, the clock is ticking, and you have about 180 days to launch. Whatever revenue trajectory is set at launch – either meeting expectations or missing them – sets the course that drug will follow for the rest of its lifetime.
Enabling sales to deliver the compelling core narrative developed by brand is the cornerstone of launch success. During training and field execution, the marketing, sales and commercial learning and development (CL&D) teams must share critical insights on what’s working, as well as areas of risk. This enables the teams to proactively detect and correct potential issues in order to prevent gaps in execution.
In this webinar, the featured speakers will share how creating transparency in training and sales performance can give insight into the brand strategy effectiveness, which will further enable your sales team to educate and build trust with key healthcare professionals (HCPs) and other stakeholders for optimal launch performance.
Register for this webinar to gain insights into how creating transparency in product launch training and aligning brand strategy with field execution can lead to a blockbuster launch.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Michael Eugene, Director of Commercial Excellence, ACTO Carl Wooten, Chief Consulting Officer - Pharma-Biotech Access, Carl Wooten Consulting
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -9-26
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|